Bausch, which last week adopted a poison-pill plan to prevent any unsolicited takeover bid, said Tuesday it has learned Icahn ...

Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity ...

(Reuters) -Billionaire Carl Icahn has built an economic interest covering about 34% of Bausch Health's shares, according to a ...

Supplement In Response to Company Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 ...

After enacting a “poison pill” defense to protect itself from unwanted potential buyers, Bausch Health has spotted a major ...

The swap agreements covering 90.7M BHC shares (24.6%) are set to mature on February 28, 2028, the company noted, adding that ...

Bausch (BHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Raymond James bullish rating for Bausch Health Companies remains unchanged after a U.S. District Court ruling.

In a report released today, Michael W. Freeman from Raymond James maintained a Hold rating on Bausch Health Companies (BHC – Research Report), ...

Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the ...

Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...

BofA lowered the firm’s price target on Bausch Health (BHC) to $5 from $7 and keeps an Underperform rating on the shares. The firm, in its ...